Skip to main content
QTRX
NASDAQ Industrial Applications And Services

Quanterix Slashes 2026 Revenue Outlook, Pushes Cash Breakeven to 2027; Q2 Revenue Misses

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$2.68
Mkt Cap
$189.837M
52W Low
$2.395
52W High
$8.77
52W Position info
12% above low
Off High info
69% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

QTRX is trading near its 52-week low of $2.395 (12% above the low).

Summary

Quanterix missed Q2 revenue expectations, cut its full-year 2026 revenue guidance by about 15%, and pushed cash flow breakeven to 2027. A $26.9 million goodwill impairment and a new Chief Commercial Officer appointment rounded out a challenging quarter.


Key Events · Earnings and Guidance · QTRX

  • Q2 Revenue Misses Expectations

    Revenue of $32.9M grew 34% YoY but fell short of internal targets due to commercial execution challenges and market softness.

  • Full-Year Guidance Slashed

    2026 revenue guidance cut to $142–148M from $169–174M; adjusted gross margin now 48–50% vs. 49–53% prior.

  • Cash Breakeven Delayed to 2027

    Cash flow breakeven pushed from H2 2026 to 2027; year-end cash balance now expected at ~$80M, down from $100M.

  • $26.9M Goodwill Impairment

    Non-cash goodwill impairment charge related to the Akoya acquisition, reflecting recent business circumstances.


Analysis · QTRX · Industrial Applications And Services

Quanterix reported Q2 revenue of $32.9 million, up 34% year-over-year but well short of expectations, and slashed its full-year 2026 revenue guidance to $142–148 million from $169–174 million. The company also pushed its cash flow breakeven target to 2027 from the second half of 2026 and now expects to exit the year with about $80 million in cash, down from $100 million previously. A $26.9 million goodwill impairment tied to the Akoya acquisition further weighed on GAAP results. On the operational side, the appointment of Jim Gute as Chief Commercial Officer signals a push to fix commercial execution, but the guidance cut and delayed profitability timeline are the dominant headlines.

At the time of this filing, QTRX was trading at $2.68 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $189.8M. The 52-week trading range was $2.40 to $8.77. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

QTRX - Latest Insights

QTRX
Jun 10, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.07
Real-time Price: $2.73 info
Change: -$0.340 (-11%) info
Market Cap: $189.837M info
QTRX
Jun 10, 2026, 3:13 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $3.20
Real-time Price: $2.73 info
Change: -$0.470 (-15%) info
Market Cap: $189.837M info
QTRX
Jun 09, 2026, 8:06 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.67
Real-time Price: $2.73 info
Change: -$0.940 (-26%) info
Market Cap: $189.837M info
QTRX
May 26, 2026, 5:25 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.68
Real-time Price: $2.73 info
Change: +$0.050 (+2%) info
Market Cap: $189.837M info
QTRX
May 12, 2026, 4:17 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.91
Real-time Price: $2.73 info
Change: -$0.180 (-6%) info
Market Cap: $189.837M info